Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Extensive CArdioVAscular Characterization and Follow-up of Patients Receiving Immune Checkpoint Inhibitors: a Prospective Multicentre Study

NCT05699915 is registered in ClinicalTrials.gov with Algemeen Ziekenhuis Maria Middelares as lead sponsor.

NCT NCT05699915
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05699915 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Extensive CArdioVAscular Characterization and Follow-up of Patients Receiving Immune Checkpoint Inhibitors: a Prospective Multicentre Study
Lead sponsor
Algemeen Ziekenhuis Maria Middelares
Phase
Not applicable
Overall status
Terminated
Start date
January 7, 2022
Completion date
July 12, 2024
Enrollment
105 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

atherosclerosis, cancer, cardiac abnormalities, variable, cardiotoxicity, diastolic dysfunction, immune checkpoint inhibitor-related myocarditis, immune-related adverse event